JULIE COX: Open Payments
NPI 1063857233 · PIERRE, SD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$593 in 25 payments from 15 companies in 2025. Trend: 2023 $127 · 2024 $722 · 2025 $593
Food & beverage: $593
| Company | Payments | Amount |
|---|---|---|
| Vanda Pharmaceuticals Inc. | 1 | $112 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | 1 | $98 |
| Janssen Pharmaceuticals, Inc | 3 | $63 |
| HARMONY BIOSCIENCES LLC | 3 | $53 |
| Alkermes, Inc. | 2 | $40 |
| Neurocrine BioSciences, Inc. | 2 | $36 |
| Indivior Inc. | 2 | $32 |
| Otsuka America Pharmaceutical, Inc. | 2 | $31 |
| Sage Therapeutics, LLC | 2 | $29 |
| Corium, LLC | 2 | $23 |
Products named: FANAPT, WAKIX, SPRAVATO, ARISTADA, INGREZZA, SUBLOCADE, ZURZUVAE, Azstarys.
Industry payments across SD — which companies pay providers there.
